These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6447505)

  • 1. Effects of benserazide, carbidopa and isoniazid administration on tryptophan-nicotinamide nucleotide metabolism in the rat.
    Bender DA
    Biochem Pharmacol; 1980 Aug; 29(15):2099-104. PubMed ID: 6447505
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition in vitro of the enzymes of the oxidative pathway of tryptophan metabolism and of nicotinamide nucleotide synthesis by benserazide, carbidopa and isoniazid.
    Bender DA
    Biochem Pharmacol; 1980 Mar; 29(5):707-12. PubMed ID: 20227944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of benserazide and carbidopa on the metabolism of L-tryptophan by isolated rat liver cells.
    Smith SA; Pogson CI
    Biochem Pharmacol; 1981 Mar; 30(6):623-8. PubMed ID: 7271899
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of benserazide on tryptophan metabolism in the mouse.
    Bender DA; Smith WR; Humm RP
    Biochem Pharmacol; 1977 Sep; 26(17):1619-23. PubMed ID: 901580
    [No Abstract]   [Full Text] [Related]  

  • 5. The metabolism of a tryptophan load in rat brain and liver: the influence of L-alpha-methyldopa hydrazine (MK-486, Carbidopa).
    Joseph MH; Hall-Tipping DL
    Biochem Soc Trans; 1978; 6(5):997-1000. PubMed ID: 744365
    [No Abstract]   [Full Text] [Related]  

  • 6. Dose and sex related effects of aromatic aminoacids decarboxylase inhibitors on serum prolactin in humans.
    Polleri A; Masturzo P; Murialdo G; Carolei A
    Acta Endocrinol (Copenh); 1980 Jan; 93(1):7-12. PubMed ID: 7355667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benserazide effects on tryptophan metabolism in mice [proceedings].
    Bender DA; Smith WR; Hobbiger F
    Br J Pharmacol; 1978 Mar; 62(3):454P. PubMed ID: 638371
    [No Abstract]   [Full Text] [Related]  

  • 8. Human pharmacokinetics of long term 5-hydroxytryptophan combined with decarboxylase inhibitors.
    Magnussen I; Van Woert MH
    Eur J Clin Pharmacol; 1982; 23(1):81-6. PubMed ID: 6182005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of VB6 on L-DOPA decarboxylase activity in the organs of rats given peripheral L-DOPA decarboxylase inhibitors (author's transl)].
    Yoshimine N; Kuzuya F; Mori K; Sakamoto N
    Nihon Ronen Igakkai Zasshi; 1978 Nov; 15(6):566-73. PubMed ID: 732010
    [No Abstract]   [Full Text] [Related]  

  • 10. Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism.
    Pinder RM; Brogden RN; Sawyer PR; Speight TM; Avery GS
    Drugs; 1976; 11(5):329-77. PubMed ID: 782834
    [No Abstract]   [Full Text] [Related]  

  • 11. Aterial blood pressure in dogs: effects of m-tyrosine alone or in combination with inhibitors of aromatic amino acid decarboxylase; relative hypotensive potencies of L-dopa, DL-m-tyrosine, and L-m-tyrosine.
    Minsker DH; Stokes AL
    Experientia; 1974 Sep; 30(9):1051-3. PubMed ID: 4412113
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of some decarboxylase inhibitors on striatal tyramines in the mouse.
    Juorio AV
    Neuropharmacology; 1983 Jan; 22(1):71-3. PubMed ID: 6843786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large amounts of picolinic acid are lethal but small amounts increase the conversion of tryptophan-nicotinamide in rats.
    Shibata K; Fukuwatari T
    J Nutr Sci Vitaminol (Tokyo); 2014; 60(5):334-9. PubMed ID: 25744422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of decarboxylase and levels of dopa and 3-O-methyldopa: a comparative study of benserazide versus carbidopa in rodents and of Madopar standard versus Madopar HBS in volunteers.
    Da Prada M; Kettler R; Zürcher G; Schaffner R; Haefely WE
    Eur Neurol; 1987; 27 Suppl 1():9-20. PubMed ID: 3123242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dietary tryptophan levels on the urinary excretion of nicotinamide and its metabolites in rats fed a niacin-free diet or a constant total protein level.
    Shibata K; Matsuo H
    J Nutr; 1990 Oct; 120(10):1191-7. PubMed ID: 2145404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of hepatic aldehyde dehydrogenase by carbidopa.
    Messiha FS
    Res Commun Chem Pathol Pharmacol; 1978 Jun; 20(3):601-4. PubMed ID: 674836
    [No Abstract]   [Full Text] [Related]  

  • 17. Contributions of tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase to the conversion of D-tryptophan to nicotinamide analyzed by using tryptophan 2,3-dioxygenase-knockout mice.
    Maeta A; Sano M; Fukuwatari T; Funakoshi H; Nakamura T; Shibata K
    Biosci Biotechnol Biochem; 2014; 78(5):878-81. PubMed ID: 25035993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of L-tryptophan on motor activity and its prevention by an extracerebral decarboxylase inhibitor and by 5-HT receptor blockers.
    Tricklebank MD; Drewitt PN; Curzon G
    Psychopharmacology (Berl); 1980; 69(2):173-7. PubMed ID: 6779309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benserazide decreases central AADC activity, extracellular dopamine levels and levodopa decarboxylation in striatum of the rat.
    Jonkers N; Sarre S; Ebinger G; Michotte Y
    J Neural Transm (Vienna); 2001; 108(5):559-70. PubMed ID: 11459076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tryptophan metabolism as affected by anovulatory agents.
    Brown RR; Rose DP; Price JM; Wolf H
    Ann N Y Acad Sci; 1969 Sep; 166(1):44-56. PubMed ID: 4243378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.